MicroRNA expression profiles classify human cancers
- PMID: 15944708
- DOI: 10.1038/nature03702
MicroRNA expression profiles classify human cancers
Abstract
Recent work has revealed the existence of a class of small non-coding RNA species, known as microRNAs (miRNAs), which have critical functions across various biological processes. Here we use a new, bead-based flow cytometric miRNA expression profiling method to present a systematic expression analysis of 217 mammalian miRNAs from 334 samples, including multiple human cancers. The miRNA profiles are surprisingly informative, reflecting the developmental lineage and differentiation state of the tumours. We observe a general downregulation of miRNAs in tumours compared with normal tissues. Furthermore, we were able to successfully classify poorly differentiated tumours using miRNA expression profiles, whereas messenger RNA profiles were highly inaccurate when applied to the same samples. These findings highlight the potential of miRNA profiling in cancer diagnosis.
Comment in
-
Cancer genomics: small RNAs with big impacts.Nature. 2005 Jun 9;435(7043):745-6. doi: 10.1038/435745a. Nature. 2005. PMID: 15944682 No abstract available.
-
miRNAs, cancer, and stem cell division.Cell. 2005 Jul 15;122(1):6-7. doi: 10.1016/j.cell.2005.06.036. Cell. 2005. PMID: 16009126 Review.
Similar articles
-
Multiclass cancer classification using a feature subset-based ensemble from microRNA expression profiles.Comput Biol Med. 2017 Jan 1;80:39-44. doi: 10.1016/j.compbiomed.2016.11.008. Epub 2016 Nov 21. Comput Biol Med. 2017. PMID: 27889431
-
Multi-class cancer classification through gene expression profiles: microRNA versus mRNA.J Genet Genomics. 2009 Jul;36(7):409-16. doi: 10.1016/S1673-8527(08)60130-7. J Genet Genomics. 2009. PMID: 19631915
-
Exploring microRNA Regulation of Cancer with Context-Aware Deep Cancer Classifier.Pac Symp Biocomput. 2019;24:160-171. Pac Symp Biocomput. 2019. PMID: 30864319
-
MicroRNA expression profiling in cancer from a bioinformatics prospective.Expert Rev Mol Diagn. 2007 Nov;7(6):787-92. doi: 10.1586/14737159.7.6.787. Expert Rev Mol Diagn. 2007. PMID: 18020908 Review.
-
microRNAs and cancer: role in tumorigenesis, patient classification and therapy.Clin Transl Oncol. 2007 Mar;9(3):155-60. doi: 10.1007/s12094-007-0029-0. Clin Transl Oncol. 2007. PMID: 17403626 Review.
Cited by
-
Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions.Biomolecules. 2024 Oct 16;14(10):1306. doi: 10.3390/biom14101306. Biomolecules. 2024. PMID: 39456239 Free PMC article. Review.
-
Loss of miR-634 contributes to the formation FOXA1-positive triple negative breast cancer subtype.Discov Oncol. 2024 Oct 23;15(1):584. doi: 10.1007/s12672-024-01472-5. Discov Oncol. 2024. PMID: 39441384 Free PMC article.
-
Investigating the interplay between the mir-183/182/96 cluster and the adherens junction pathway in early-stage breast cancer.Sci Rep. 2024 Oct 21;14(1):24711. doi: 10.1038/s41598-024-73632-0. Sci Rep. 2024. PMID: 39433788 Free PMC article.
-
Understanding the Dosage-Dependent Role of Dicer1 in Thyroid Tumorigenesis.Int J Mol Sci. 2024 Oct 4;25(19):10701. doi: 10.3390/ijms251910701. Int J Mol Sci. 2024. PMID: 39409030 Free PMC article.
-
Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment.Onco Targets Ther. 2024 Sep 25;17:785-801. doi: 10.2147/OTT.S475132. eCollection 2024. Onco Targets Ther. 2024. PMID: 39345275 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
